Koers Aura Health Inc Toronto S.E.
Aandelen
GIR
CA5134413031
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 4,81 mln. 6,59 mln. 4,4 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -8 mln. -10,96 mln. -7,32 mln. | Nettowinst (verlies) 2023 | -13 mln. -17,8 mln. -11,9 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,09 mln. 1,5 mln. 1 mln. | Nettoschuld 2023 | 1,34 mln. 1,84 mln. 1,23 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,59
x | K/w-verhouding 2023 |
-0,24
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 98,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Steen
CEO | Chief Executive Officer | - | 06-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul McClory
BRD | Director/Board Member | 80 | 20-12-16 |
David Kideckel
CHM | Chairman | - | 30-08-21 |
Robert Steen
CEO | Chief Executive Officer | - | 06-09-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,48% | 75,74 mld. | |
-4,56% | 23,24 mld. | |
+17,81% | 8,76 mld. | |
-31,67% | 6,69 mld. | |
+20,57% | 5,58 mld. | |
+4,12% | 4,22 mld. | |
-3,94% | 3,99 mld. | |
+14,24% | 3,39 mld. | |
+10,59% | 3,23 mld. |